[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351589-105":59,"doc-detail-351589-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","deciphering-lung-adenocarcinoma-heterogeneity-a-multi-omics-approach-reveals-nuclear-division-fibroblasts-as-prognosticators-and-therapeutic-targets","Deciphering lung adenocarcinoma heterogeneity: a multi-omics approach reveals nuclear division fibroblasts as prognosticators and therapeutic targets","","Lung adenocarcinoma (LUAD) remains a leading cause of cancer-related mortality, yet the heterogeneity and prognostic value of lung-associated fibroblasts (LAFs) in the tumor microenvironment (TME) are not fully defined. This study used multi-omics integration to identify LAF subsets across pulmonary disease stages, determine LAF subpopulations linked to LUAD prognosis, and build an LAF-derived prognostic signature. A nuclear division LAF (nLAF) risk score model and gene signature were constructed and assessed for clinical outcome prediction, along with TME immune infiltration and therapy response implications.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/deciphering-lung-adenocarcinoma-heterogeneity-a-multi-omics-approach-reveals-nuclear-division-fibroblasts-as-prognosticators-and-therapeutic-targets/351589/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/deciphering-lung-adenocarcinoma-heterogeneity-a-multi-omics-approach-reveals-nuclear-division-fibroblasts-as-prognosticators-and-therapeutic-targets/351589.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in lung adenocarcinoma (LUAD)?","Question",{"text":112,"@type":113},"The study targets the incomplete understanding of lung-associated fibroblast (LAF) heterogeneity and how specific LAF subsets relate to LUAD prognosis within the tumor microenvironment (TME).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the nuclear division LAF risk model (nLRS) developed and validated?",{"text":117,"@type":113},"Using multi-omics data—bulk RNA-seq from 2719 patients, single-cell RNA-seq from 368,904 cells, and spatial transcriptomics from 15,673 spots—machine learning combinations were applied to construct and validate an nLAFs risk score prediction model.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical or biological implications were associated with high vs low nLRS groups?",{"text":121,"@type":113},"High nLRS was linked to LUAD prognosis differences, distinct immune cell infiltration and biological functions in the TME, potential resistance to immunotherapy in pan-cancer settings, and increased sensitivity to chemotherapeutic and targeted therapies in preclinical models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351589,1791269545,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Cao et al. Journal of Translational Medicine (2026) 24:610  \n[https://doi.org/10.1186/s12967-026-08022-3](https://doi.org/10.1186/s12967-026-08022-3)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nDeciphering lung adenocarcinoma heterogeneity: a multi-omics approach reveals nuclear division fibroblasts as prognosticators and therapeutic targets  \nPeng Cao1†, Yongxia Qin2†, Dingtao Hu3, Tengfei Ge4, Peng Zhang1, Chao Cheng1,1, Shun Wang5, Shuhui Hu 1, Zhen Zhang6 and Ling Xu1*  \nAbstract  \nBackground Lung adenocarcinoma (LUAD) is a predominant contributor to cancer‑related mortality globally. Lung‑associated fibroblasts (LAFs) are intricately linked to tumorigenesis and the tumor microenvironment (TME), but their heterogeneity and prognostic relevance in LUAD remain incompletely understood. This study aimed to systematically characterize LAF subsets across the spectrum of pulmonary disease, identify LAF subpopulations associated with LUAD prognosis, and construct a robust LAF‑based prognostic signature.  \nMethods We employed a multi‑omics approach, leveraging bulk RNA data of 2719 patients from 19 LUAD cohorts, single‑cell RNA (scRNA) sequencing data of 368,904 cells from 93 samples, and spatial transcriptomics data of 15,673 spots from 6 samples to characterize the landscape of LAFs across various stages of pulmonary disease. We employed multiple advanced machine learning algorithms to construct and validate a robust nuclear division LAFs (nLAFs) risk score (nLRS) prediction model.  \nResults We observed a dynamic and gradual increase in the proportion of LAFs during the progression of LUAD. Throughout this process, we identified nine LAFs subtypes and found nLAFs are significantly associated with the prognosis of LUAD. Utilizing 100 machine learning algorithm combinations and integrating nLAFs marker genes, we developed a five gene based nLRS model, which demonstrated superior performance than other 49 published models in predicting clinical outcomes for LUAD. Additionally, we observed distinct biological functions and immune cell infiltration in theTME between high and low nLRS groups. Exploratory analysis of pan‑cancer immunotherapy cohorts suggested that patients with high nLRS scores may exhibit resistance to immunotherapy in some cancer types, but prospective validation in LUAD‑specific cohorts is required. Conversely, high nLRS patients displayed increased sensitivity to chemotherapeutic and targeted therapies in preclinical models.  \n†Peng Cao, Yongxia Qin and Dingtao Hu contributed equally to this work.  \n*Correspondence:  \nLing Xu [xuling810628@126.com](xuling810628@126.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nCao et al. Journal of Translational Medicine (2026) 24:610 Page 2 of 27  \nConclusion Our study introduces a candidate five‑gene signature derived from nLAFs that may serve as a robust prognostic biomarker pending prospective validation, offering insights into personalized therapeutic strategies for LUAD pati","cbCaiqGaSJicn4O0","https://ap.wps.com/l/cbCaiqGaSJicn4O0","pdf",28153109,27,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## LUAD prognosis and heterogeneity","[{\"question\":\"What problem does the study address in lung adenocarcinoma (LUAD)?\",\"answer\":\"The study targets the incomplete understanding of lung-associated fibroblast (LAF) heterogeneity and how specific LAF subsets relate to LUAD prognosis within the tumor microenvironment (TME).\"},{\"question\":\"How was the nuclear division LAF risk model (nLRS) developed and validated?\",\"answer\":\"Using multi-omics data—bulk RNA-seq from 2719 patients, single-cell RNA-seq from 368,904 cells, and spatial transcriptomics from 15,673 spots—machine learning combinations were applied to construct and validate an nLAFs risk score prediction model.\"},{\"question\":\"What clinical or biological implications were associated with high vs low nLRS groups?\",\"answer\":\"High nLRS was linked to LUAD prognosis differences, distinct immune cell infiltration and biological functions in the TME, potential resistance to immunotherapy in pan-cancer settings, and increased sensitivity to chemotherapeutic and targeted therapies in preclinical models.\"}]","Deciphering lung adenocarcinoma heterogeneity: a multi-omics approach reveals nuclear division fibroblasts as prognosticators and therapeutic targets | PDF",1790094855,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1728acbd0bd3236be086f562bbc772ae.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d088e56f17df71e18a91666d0ee4a3b5.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de4fe1cd28199663acc19fa2be877932.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2139c98681c3a482cb38346425b137d1.webp",980,1306]